VERAXA Biotech advances VXA-222 bispecific ADC program with OmniAb

Go back to VERAXA Biotech advances VXA-222 bispecific ADC program with OmniAb
(NASDAQ: OABI) Delayed: 4.92 +0.05 (1.03%)
Previous Close $4.87    52 Week High $ 
Open $4.83    52 Week Low $ 
Day High $5.02    P/E N/A 
Day Low $4.64    EPS $ 
Volume 1,215,145       

(NASDAQ: VRXA) Delayed: 1.13 --0 (-0%)
Previous Close $1.13    52 Week High $ 
Open $1.13    52 Week Low $ 
Day High $1.16    P/E N/A 
Day Low $1.12    EPS $ 
Volume 154,077